TFV + LNG Vaginal Ring

Product Overview

Alternative Name: Tenofovir (TFV) and levonorgestrel (LNG) ring

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Vaginal Ring

Duration Type: Long-acting

Description: An ARV-based microbicide, tenofovir, and a progestin-only contraceptive, levonorgestrel, in a two-segment polyurethane vaginal ring.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Early Development

Project Stage: Phase I

Status Details:
  • Phase 1 with 30-day ring planned for late 2014. Currently in clinical product GMP manufacturing and IND submission. Phase 1 planned for Dominican Republic and at Eastern Virginia Medical School (EVMS).

Download Product Report